JP2009538935A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538935A5 JP2009538935A5 JP2009513472A JP2009513472A JP2009538935A5 JP 2009538935 A5 JP2009538935 A5 JP 2009538935A5 JP 2009513472 A JP2009513472 A JP 2009513472A JP 2009513472 A JP2009513472 A JP 2009513472A JP 2009538935 A5 JP2009538935 A5 JP 2009538935A5
- Authority
- JP
- Japan
- Prior art keywords
- myxoma virus
- activity
- group
- cancer
- myxoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80364006P | 2006-06-01 | 2006-06-01 | |
| PCT/US2007/070219 WO2007143548A2 (en) | 2006-06-01 | 2007-06-01 | Myxoma virus mutants for cancer treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013040387A Division JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538935A JP2009538935A (ja) | 2009-11-12 |
| JP2009538935A5 true JP2009538935A5 (enExample) | 2010-07-08 |
Family
ID=38802246
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513472A Withdrawn JP2009538935A (ja) | 2006-06-01 | 2007-06-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2013040387A Expired - Fee Related JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2014248831A Pending JP2015044878A (ja) | 2006-06-01 | 2014-12-09 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2016197808A Pending JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013040387A Expired - Fee Related JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2014248831A Pending JP2015044878A (ja) | 2006-06-01 | 2014-12-09 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2016197808A Pending JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8512713B2 (enExample) |
| EP (3) | EP3254694A1 (enExample) |
| JP (4) | JP2009538935A (enExample) |
| KR (1) | KR20090014364A (enExample) |
| CN (1) | CN101460194B (enExample) |
| AU (1) | AU2007256754B2 (enExample) |
| CA (2) | CA2652228C (enExample) |
| IL (1) | IL195297A (enExample) |
| MX (1) | MX2008015265A (enExample) |
| NZ (1) | NZ572893A (enExample) |
| WO (1) | WO2007143548A2 (enExample) |
| ZA (1) | ZA200809769B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2652228C (en) | 2006-06-01 | 2017-07-11 | Robarts Research Institute | Myxoma virus mutants for cancer treatment |
| FR2946536B1 (fr) | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| WO2019227022A1 (en) | 2018-05-25 | 2019-11-28 | Bioventures, Llc | Myxoma virus compositions and methods of use |
| AU2019336180A1 (en) * | 2018-09-05 | 2021-04-15 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| US12428626B2 (en) | 2018-11-20 | 2025-09-30 | Bioventures, Llc | Cells for the production of viruses and methods of using the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2305269C (en) | 1997-10-09 | 2012-07-03 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| ES2153284B1 (es) | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| CN1477964A (zh) | 1999-04-15 | 2004-02-25 | 应用病毒治疗肿瘤 | |
| CA2378567A1 (en) | 1999-07-12 | 2001-01-18 | Viron Therapeutics, Inc. | Novel myxoma genes for immune modulation |
| AU2001261738A1 (en) | 2000-05-17 | 2001-11-26 | London Health Sciences Centre | Compositions and methods for promoting immunosuppression |
| DK1370668T3 (da) * | 2001-03-08 | 2006-06-06 | Akzo Nobel Nv | Leporipox-baserede vektorvacciner |
| MXPA05009526A (es) | 2003-03-07 | 2005-12-15 | Robarts Res Inst | Uso de virus de mixoma para el tratamiento terapeutico de cancer e infeccion viral cronica. |
| NZ550430A (en) | 2004-04-27 | 2009-06-26 | Wellstat Biologics Corp | Cancer treatment using viruses and camptothecins |
| MX2007010962A (es) | 2005-03-07 | 2008-03-10 | Robarts Res Inst | Uso de una combinacion de virus myxoma y rapamicina para tratamiento terapeutico. |
| WO2007143545A2 (en) | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Tnf signaling in myxoma virus treatments |
| CA2652228C (en) | 2006-06-01 | 2017-07-11 | Robarts Research Institute | Myxoma virus mutants for cancer treatment |
| WO2007147118A1 (en) | 2006-06-16 | 2007-12-21 | Robarts Research Institute | Infection of cells with myxoma virus requires akt activation |
-
2007
- 2007-06-01 CA CA2652228A patent/CA2652228C/en not_active Expired - Fee Related
- 2007-06-01 JP JP2009513472A patent/JP2009538935A/ja not_active Withdrawn
- 2007-06-01 US US12/301,961 patent/US8512713B2/en not_active Expired - Fee Related
- 2007-06-01 AU AU2007256754A patent/AU2007256754B2/en not_active Ceased
- 2007-06-01 CA CA2951453A patent/CA2951453A1/en not_active Abandoned
- 2007-06-01 NZ NZ572893A patent/NZ572893A/en not_active IP Right Cessation
- 2007-06-01 WO PCT/US2007/070219 patent/WO2007143548A2/en not_active Ceased
- 2007-06-01 EP EP17182211.7A patent/EP3254694A1/en not_active Withdrawn
- 2007-06-01 EP EP11184754.7A patent/EP2457584B1/en not_active Not-in-force
- 2007-06-01 EP EP07798014A patent/EP2021023A4/en not_active Withdrawn
- 2007-06-01 CN CN2007800202887A patent/CN101460194B/zh not_active Expired - Fee Related
- 2007-06-01 KR KR1020087029274A patent/KR20090014364A/ko not_active Ceased
- 2007-06-01 MX MX2008015265A patent/MX2008015265A/es active IP Right Grant
-
2008
- 2008-11-13 IL IL195297A patent/IL195297A/en active IP Right Grant
- 2008-11-13 ZA ZA200809769A patent/ZA200809769B/xx unknown
-
2013
- 2013-03-01 JP JP2013040387A patent/JP5665899B2/ja not_active Expired - Fee Related
- 2013-08-19 US US13/969,853 patent/US20130336930A1/en not_active Abandoned
-
2014
- 2014-12-09 JP JP2014248831A patent/JP2015044878A/ja active Pending
-
2016
- 2016-01-21 US US15/002,971 patent/US9980994B2/en active Active
- 2016-10-06 JP JP2016197808A patent/JP2017008105A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| He et al. | Oxidative stress, inflammation, and autophagy: potential targets of mesenchymal stem cells-based therapies in ischemic stroke | |
| JP6759402B2 (ja) | Ｆｌｔ３変異を有する急性骨髄性白血病の治療用の医薬組成物 | |
| Bloy et al. | Trial watch: radioimmunotherapy for oncological indications | |
| Geng et al. | Biomimetic nanovehicle-enabled targeted depletion of intratumoral Fusobacterium nucleatum synergizes with PD-L1 blockade against breast cancer | |
| CN111065639A (zh) | 一类细胞周期依赖性激酶的降解剂、其制备方法、药物组合物及其用途 | |
| NO20075046L (no) | Gastroresistente farmasoytiske formuleringer inneholdende rifaximin | |
| JP2007513190A5 (enExample) | ||
| EP1385466A4 (en) | ONCOLYTIC VIRUS THERAPY | |
| CN104884055A (zh) | 柠檬酸铁在治疗慢性肾脏疾病患者中的应用 | |
| JP7681000B2 (ja) | アフリカ豚熱を治療するための薬物組成物及びその使用 | |
| JP2011225596A5 (enExample) | ||
| JP2016539156A5 (enExample) | ||
| BRPI0411098A (pt) | benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos | |
| EA200800663A1 (ru) | Способ и средство профилактики и лечения нарушенного дыхания во время сна | |
| JP2018509388A5 (enExample) | ||
| JP2009538935A5 (enExample) | ||
| JP2006516571A5 (enExample) | ||
| JP2012107063A5 (enExample) | ||
| CN110464727A (zh) | 3,4-二氢-2h-苯并-[1,4]恶嗪类药物或其盐在制备抑制铁死亡药物中的应用 | |
| JP6099214B2 (ja) | 電離放射線誘発の損傷から哺乳類細胞を保護する医薬組成物 | |
| SE0950390L (sv) | System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför | |
| JP5665899B2 (ja) | 癌の処置のための粘液腫ウイルス変異体 | |
| CN116726021A (zh) | 一种drp1抑制剂和铁死亡诱导剂联合用药物及其抗肿瘤的用途 | |
| MX367580B (es) | El uso de lapatinib o una sal o composición farmacéuticamente aceptable del mismo para el tratamiento del cáncer. | |
| CN101711758A (zh) | 芹菜素在制备预防和治疗人缺血损伤引起疾病的药物应用 |